Login / Signup
Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia.
Zachary Braunstein
Eric McLaughlin
Anjali Mishra
Jonathan E Brammer
Published in:
Blood advances (2022)
Keyphrases
</>
acute myeloid leukemia
acute lymphoblastic leukemia
low dose
multiple myeloma
diffuse large b cell lymphoma
bone marrow
high dose
hodgkin lymphoma
single molecule